Analysis of the role of the BMP7-Smad4-Id2 signaling pathway in SW480 colorectal carcinoma cells

Molecular Medicine Reports

Volumn 4, Issue 4, 2011, Pages 627-631

  Shi, Qiang ^a   Zhong, Yun Shi ^a   Ren, Zhong ^a   Li, Quan Lin ^a   Zhou, Ping Hong ^a   Xu, Mei Dong ^a   Yao, Li Qing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

BMP7; cDNA; Colorectal carcinoma; Id2; Smad4; SW480

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COMPLEMENTARY DNA; INHIBITOR OF DIFFERENTIATION 2; MATRIGEL; OSTEOGENIC PROTEIN 1; SMAD4 PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL ASSAY; CELL COUNT; CELL STRAIN SW480; COLORECTAL CARCINOMA; CONTROLLED STUDY; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; METASTASIS; METASTASIS POTENTIAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; WESTERN BLOTTING;

BONE MORPHOGENETIC PROTEIN 7; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; SIGNAL TRANSDUCTION; SMAD4 PROTEIN;

EID: 79957640237     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.481     Document Type: Article

References (16)

1. Chen D, Zhao M and Mundy GR: Bone morphogenetic proteins. Growth Factors 22: 233-241, 2004. (Pubitemid 40136452)
2. Rockman SP, Currie SA, Ciavarella M, et al: Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. J Biol Chem 276: 45113-45119, 2001.
3. Fritah A, Saucier C, De Wever O, et al: Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol 28: 1114-1123, 2008. (Pubitemid 351160067)
4. Kowanetz M, Valcourt U, Bergstrom R, Heldin CH and Moustakas A: Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein. Mol Cell Biol 24: 4241-4254, 2004. (Pubitemid 41070996)
5. Schwarte-Waldhoff I, Klein S, Blass-Kampmann S, et al: DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18: 3152-3158, 1999. (Pubitemid 29261236)
6. Wakefield LM and Roberts AB: TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29, 2002. (Pubitemid 34094985)
7. Seoane J, Le HV, Shen L, Anderson SA and Massague J: Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223, 2004. (Pubitemid 38496241)
8. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534, 1988. (Pubitemid 19023695)
9. Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10: 1580-1594, 1996.
10. Thompson DL, Gerlach-Bank LM, Barald KF and Koenig RJ: Retinoic acid repression of bone morphogenetic protein 4 in inner ear development. Mol Cell Biol 23: 2277-2286, 2003. (Pubitemid 36351011)
11. Derynck R, Zhang Y and Feng XH: Smads: transcriptional activators of TGF-beta responses. Cell 95: 737-740, 1998. (Pubitemid 29014453)
12. Attisano L and Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 12: 235-243, 2000. (Pubitemid 30142572)
13. Massague J and Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19: 1745-1754, 2000. (Pubitemid 30204386)
14. Wrana JL and Attisano L: The Smad pathway. Cytokine Growth Factor Rev 11: 5-13, 2000. (Pubitemid 30169721)
15. Chen W, Fu X and Sheng Z: Review of current progress in the structure and function of Smad proteins. Chin Med J (Engl) 115: 446-450, 2002.
16. Moustakas A, Souchelnytskyi S and Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369, 2001. (Pubitemid 34082857)